(Q46879124)

26 December 2017

title

Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts (English)

1 reference

26 December 2017

1 reference

7

Laurence H Klotz

1 reference

26 December 2017

author name string

Vasundara Venkateswaran

1

1 reference

26 December 2017

Ahmed Q Haddad

2

1 reference

26 December 2017

Neil E Fleshner

3

1 reference

26 December 2017

Rong Fan

4

1 reference

26 December 2017

Linda M Sugar

5

1 reference

26 December 2017

Rob Nam

6

1 reference

26 December 2017

Michael Pollak

8

1 reference

26 December 2017

language of work or name

English

0 references

publication date

27 November 2007

1 reference

26 December 2017

Journal of the National Cancer Institute

published in

1 reference

26 December 2017

volume

99

1 reference

26 December 2017

issue

23

1 reference

26 December 2017

page(s)

1793-1800

1 reference

26 December 2017

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM231

Prevalence of overweight and obesity in the United States, 1999-2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM231

Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM231

Relationship between obesity and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM231

Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM231

Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM231

Obesity and prostate cancer: a growing problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM231

Are findings from studies of obesity and prostate cancer really in conflict?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM231

Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM231

Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM231

Signalling role of adipose tissue: adipokines and inflammation in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM231

Role of diet in prostate cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM231

Cancer progression in the transgenic adenocarcinoma of mouse prostate mouse is related to energy balance, body mass, and body composition, but not food intake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM231

Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM231

Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM231

Prostate cancer risk and serum levels of insulin and leptin: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM231

Serum insulin level, disease stage, prostate specific antigen (PSA) and Gleason score in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM231

Insulin-like growth factors and neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM231

Exploiting the PI3K/AKT pathway for cancer drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM231

Nutrition, insulin, insulin-like growth factors and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM231

Fasting serum glucose level and cancer risk in Korean men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM231

Hepatocellular neoplasms induced by low-number pancreatic islet transplants in autoimmune diabetic BB/Pfd rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM231

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM231

Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM231

Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM231

Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham Offspring Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM231

Increased insulin-like growth factor I receptor expression and signaling are components of androgen-independent progression in a lineage-derived prostate cancer progression model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM231

Interaction of IGF signaling and the androgen receptor in prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM231

Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM231

Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM231

Insulin sensitivity during combined androgen blockade for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM231

Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM231

Is there a role for a low-carbohydrate ketogenic diet in the management of prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM231

Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese, normal-weight individual

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM231

Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM231

Association of energy intake with prostate cancer in a long-term aging study: Baltimore longitudinal study of aging (United States)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM231

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJM231

1 reference

26 December 2017

1 reference

26 December 2017